Invited commentary: Genes, environment, and hybrid vigor

American Journal of Epidemiology

Volumn 170, Issue 6, 2009, Pages 703-707

  Gwinn, Marta ^a   Guessous, Idris ^a,b   Khoury, Muin J ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Case control studies; DNA damage; DNA repair; Genetic predisposition to disease; Lung neoplasms; Oxoguanine glycosylase 1, human; Smoking

Indexed keywords

8 HYDROXYGUANINE; 8 OXOGUANINE DNA N GLYCOSYLASE 1; CYSTEINE; DNA GLYCOSYLTRANSFERASE; SERINE; UNCLASSIFIED DRUG;

CANCER RISK; CASE CONTROL STUDY; DATA ANALYSIS; GENE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENOMICS; HUMAN; LUNG CANCER; NOTE; RISK FACTOR; SMOKING;

DNA GLYCOSYLASES; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYBRID VIGOR; LUNG NEOPLASMS; RISK FACTORS; SMOKING; TAIWAN;

EID: 69949162875     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp221     Document Type: Note

References (44)

1. World Health Organization. The Tobacco Atlas. Geneva, Switzerland: World Health Organization; 2002. (http:// www.who.int/tobacco/statistics/tobacco- atlas/en/). (Accessed May 1, 2009).
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030 [electronic article]. PLoS Med. 2006;3(11):e442.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
4. Food and Agriculture Organization of the United Nations. Issues in the Global Tobacco Economy. 3 Tobacco in the People's Republic of China. Rome, Italy: Food and Agriculture Organization of the United Nations; 2003. (http:// www.fao.org/docrep/006/y4997e/y4997e0g.htm). (Accessed May 1, 2009).
5. Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584-594. (Pubitemid 351720831)
6. Gu D, Kelly TN, Wu X, et al. Mortality attributable to smoking in China. N Engl J Med. 2009;360(2):150-159.
7. Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health. 1987;77(4): 425-431.
8. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257): 323-329.
9. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825-833. (Pubitemid 41486445)
10. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008:359(13): 1367-1380.
11. Ritchie JC, Idle JR. Population studies of polymorphism in drug oxidation and its relevance to carcinogenesis. IARC Sci Publ. 1982;(39):381-394.
12. Vineis P, Manuguerra M, Kavvoura FK, et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst. 2009;101(1):24-36.
13. Yu W, Gwinn M, Clyne M, et al. A navigator for human genome epidemiology. Nat Genet. 2008;40(2): 124-125.
14. Dong LM, Potter JD, White E, et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299(20):2423-2436. (Pubitemid 351749241)
15. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452(7187):633-637.
16. Spinola M, Leoni VP, Galvan A, et al. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett. 2007;251(2):311-316. (Pubitemid 46669803)
17. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet, 2008;40(5):616-622. (Pubitemid 351601203)
18. Galvan A, Falvella FS, Spinola M, et al. A polygenic model with common variants may predict lung adenocarcinoma risk in humans. Int J Cancer. 2008;123(10):2327-2330.
19. Liu P, Vikis HG, Wang D, Lu Y, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst. 2008;100(18):1326-1330.
20. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008; 40(12): 1407-1409.
21. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008;40( 12): 14041406.
22. Ioannidis JP. Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. J Natl Cancer Inst. 2006;98(19):1350-1353.
23. Chang CH, Hsiao CF, Chang GC, et al. Interactive effect of cigarette smoking with human 8-oxoguanine DNA JV-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Am J Epidemiol. 2009;170(6): 695-702.
24. Hung RJ, Christiani DC, Risch A, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3081-3089.
25. Li H, Hao X, Zhang W, et al. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1739-1745.
26. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001;153(10):1016-1020.
27. Wacholder S, Chatterjee N, Caporaso N. Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer. J Natl Cancer Inst. 2008;100(21):1488-1491.
28. Merikangas KR, Risch N. Genomic priorities and public health. Science. 2003;302(5645):599-601.
29. Carlsten C, Burke W. Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. JAMA. 2006;296(20):24802482. (Pubitemid 44791205)
30. Khoury MJ, Davis R, Gwinn M, et al. Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol. 2005;161(9):799-805. (Pubitemid 40577833)
31. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002;3(8):461-469.
32. Field JK. Lung cancer risk models come of age. Cancer Prev Res (Phila Pa). 2008;1(4):226-228.
33. Khoury MJ, Wacholder S. Invited commentary: from genomewide association studies to gene-environment-wide interaction studies-challenges and opportunities. Am J Epidemiol. 2009;169(2):227-230.
34. Taioli E. Gene-environment interaction in tobacco-related cancers. Carcinogenesis. 2008:29(8):1467-1474.
35. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002;21(45):6870-6876. (Pubitemid 35221933)
36. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61(7):634-645. (Pubitemid 351766746)
37. Landi MT, Consonni D, Rotunno M, et al. Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health. 2008;8:203. (Pubitemid 352000598)
38. Khoury MJ, Little J. Human Genome Epidemiologic reviews: the beginning of something HuGE. Am J Epidemiol. 2000; 151(1):2-3. (Pubitemid 30470390)
39. Wu T, Hu Y, Chen C, et al. Passive smoking, metabolic gene polymorphisms, and infant birth weight in a prospective cohort study of Chinese women. Am J Epidemiol. 2007;166(3):313-322. (Pubitemid 47216817)
40. Süsser M. Does risk factor epidemiology put epidemiology at risk? Peering into the future. J Epidemiol Community Health. 1998;52(10):608-611. (Pubitemid 28464047)
41. Davey Smith G, Ebrahim S. Epidemiology-is it time to call it a day? Int J Epidemiol. 2001;30(1):1-11.
42. Ray R, Loughead J, Wang Z, et al. Neuroimaging, genetics and the treatment of nicotine addiction. Behav Brain Res. 2008; 193(2): 159-169.
43. Vineis P, Kriebel D. Causal models in epidemiology: past inheritance and genetic future [electronic article]. Environ Health. 2006;5:21. (Pubitemid 44318800)
44. Pearce N. Commentary: the rise and rise of corporate epidemiology and the narrowing of epidemiology's vision. Int J Epidemiol. 2007;36(4):713-717. (Pubitemid 47394133)